Cambridge Healthtech Institute’s 12th Annual

Improving Study Start-up and Performance in Multi-Center and Decentralized Trials

Strategically Implementing Process, Tech and Systems for Rapid Study Start-Up and Execution of Trials

February 9-10, 2022


Advisory Board:
Oriol Serra Ortiz, Head, Site Intelligence & Site Selection, Study Optimization Global Product Development, Pfizer Inc.
Michelle Shogren, Senior Director Innovation, Pharma R&D Clinical Operations, Bayer HealthCare
Sandra Smyth, Director, Global Feasibility and Site Intelligence, AstraZeneca

KK Rumrill, Head, Site-Facing and Study Optimization Technologies, IQVIA
Chris Hoyle, CEO and Founder, Elite Research Network
Maria Koutsopoulou, Vice President, Clinical Trial Execution, EMD Serono, Inc.


I am pleased to announce CHI’s 12th Annual Improving Study Start-Up and Performance in Site-Centered and Hybrid Trials, being held February 9-10, 2022, at Rosen Shingle Creek in Orlando, FL. The gathering will be part of the 13th Annual Summit for Clinical Trials Operations Executives (SCOPE), a four-day cluster of events taking place February 7-10 that attracts more than 2,200 leaders in clinical innovation, operations and research. Topics to be discussed at the Improving Study Start-Up and Performance in Site-Centered and Hybrid Trials” conference include: 

  • Future state of trials due to COVID-19: Planning for and enabling smooth start up in multi-center, hybrid and decentralized trials
  • Improving feasibility process, contract and budget negotiations, site selection and payments process
  • Optimizing site, patient, CRO, and sponsor interactions to improve study start-up and performance
  • Improving clinical study planning and ops through patient-centric initiatives: How do we meet the patient where they are (planning, process, technology)?
  • Understanding your protocol and its burden on patients, clin ops teams, sites and caregivers: Where can simplification of complex study activation processes help?
  • Overcoming challenges in clinical operations and site management: Innovative approaches to ensure compliance and improve quality
  • Understanding patients and site relationships to improve start-up times and site performance: Site investigators’ experience, informed consent, payments
  • Identifying the right investigators for your study and then implementing a process for effective communication
  • How are sponsors supporting sites with digital outreach?
  • How COVID changed the way we recruit: Challenges and outcomes to implementing digital strategies to accelerate recruitment
  • Driving innovation in study start-up: Optimizing processes, training leaders and leveraging technology
  • e-Consent implementation lessons learned by study experts
  • Why are there barriers to the adoption of innovative processes and technologies at sites?


*Also, please check out the Participant Engagement Award in honor of Gerald “Jerry” Matczak and the Masters in Clinical Research Golf Tournament.

If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is July 23, 2021.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:

Micah Lieberman

Executive Director

Cambridge Healthtech Institute

Phone: (+1) 541-482-4709



For partnering and sponsorship information, please contact:

Companies A-K

Ilana Quigley

Sr. Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5457



Companies L-Z

Patty Rose

Sr. Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1349


Submit a Speaker Proposal